Oncotelic Therapeutics, Inc. — Form D

Oncotelic Therapeutics, Inc. of AGOURA HILLS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-07. The offering totals $27.0M, of which $27.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
VUONG TRIEUDirectorAGOURA HILLS, CA
VUONG TRIEUExecutive OfficerAGOURA HILLS, CA
VUONG TRIEURelated PersonAGOURA HILLS, CA
Steven KingRelated PersonAGOURA HILLS, CA
James B MurphyExecutive OfficerWORCESTER, MA
Amit ShahExecutive OfficerSAN MATEO, CA
Saran SaundExecutive OfficerAGOURA HILLS, CA
Saran SaundRelated PersonAGOURA HILLS, CA
Seymour FeinExecutive OfficerAGOURA HILLS, CA
Seymour FeinRelated PersonAGOURA HILLS, CA
Anthony MaidaExecutive OfficerRaleigh, NC
Anthony MaidaRelated PersonRaleigh, NC
William SchwietermanDirectorHouston, TX
BOBBY W SANDAGE, JR.DirectorST. LOUIS, MO
Chuho ParkExecutive OfficerAgoura Hills, CA
Fatih UckunExecutive OfficerAgoura Hills, CA
Chulho ParkExecutive OfficerAgoura Hills, CA
Matthew LoarExecutive OfficerSouth San Francisco, CA
Roy H FicklingDirectorAtlanta, GA
William D SchwietermanDirectorSouth San Francisco, CA
William D SchwietermanExecutive OfficerSouth San Francisco, CA
Simon C PedderDirectorSouth San Francisco, CA
David J ChaplinDirectorSouth San Francisco, CA
David J ChaplinExecutive OfficerSouth San Francisco, CA
Donald R ReynoldsDirectorCharlotte, NC

Other filings by this issuer (7)

FiledFormOfferingSold
2026-07-22D$712K$712K
2025-12-11D$12.5M$275K
2023-07-13D$5.0M
2020-08-04D$5.0M$2.0M
2019-05-07D$1.2M$600K
2018-04-25D$12.0M$2.9M
2010-03-26D$7.5M$7.5M

More